These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 381833)

  • 1. [Therapy of acute and chronic hepatitis. A clinical study using Inzolen infusion AM].
    Köhler FR; Ebel J
    Med Welt; 1979 Jul; 30(27):1056-60. PubMed ID: 381833
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary elimination of purine and pyrimidine under the therapeutic influence of aspartic acid in chronic hepatitis].
    Iencica R; Suciu A
    Stud Cercet Med Interna; 1972; 13(1):63-70. PubMed ID: 5022327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
    Iencica R
    Med Interna (Bucur); 1972 Dec; 24(12):1449-53. PubMed ID: 4655566
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the metabolism of l-asparaginic acid (author's transl)].
    von Jagow G
    Arzneimittelforschung; 1976; 26(9):1715-6. PubMed ID: 1036707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction].
    Kosozu K
    Iryo; 1966 Apr; 20(4):339-46. PubMed ID: 5974192
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate].
    Seki S
    Iryo; 1966 Apr; 20(4):354-63. PubMed ID: 5974194
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of the aspartic acid on the amelioration of hepatic protein synthesis in chronic hepatitis. Study of 75 Se-selenomethionine incorporation in plasma albumins and globulins.
    Fodor O; Szăntay I; Cotul S; Szabŏ P; Iencica R
    Rev Roum Med Intern; 1972; 9(2):157-60. PubMed ID: 5073073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 10. [Some trends in therapy of chronic hepatitis].
    Fodor O
    Med Interna (Bucur); 1968 Oct; 20(10):1155-60. PubMed ID: 4898794
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized controlled clinical trials in diseases of the liver.
    Chalmers TC
    Prog Liver Dis; 1976; 5():450-6. PubMed ID: 775550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of arginine thiazolidine carboxylate in the treatment of chronic hepatitis. Preliminary findings].
    Bramato C; Salassa B; Soranzo ML; Bosio G; Andreoni G
    Minerva Dietol Gastroenterol; 1982; 28(1):65-70. PubMed ID: 7043311
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic results of the use of Leukeran as an immunosuppressive agent in chronic hepatitis].
    Phlippen R; Schumacher K; Gross R; Eder M
    Tijdschr Gastroenterol; 1970; 13(2):114-28. PubMed ID: 4921502
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for acute and chronic hepatitis.
    Dienstag JL; Isselbacher KJ
    Arch Intern Med; 1981 Oct; 141(11):1419-23. PubMed ID: 7025776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of glucocorticoid therapy on protein synthesis in liver punctates in patients with acute hepatitis].
    Richter E; Rotter S; Leinweber B; Liehr H; Brachtel D; Kühn HA
    Acta Hepatosplenol; 1970; 17(2):84-9. PubMed ID: 5524293
    [No Abstract]   [Full Text] [Related]  

  • 16. [Open clinical experience with uridine-diphosphoglucose in icteric hepatopathies of acute and chronic course].
    Güemes Díaz F; Conesa Picó OR; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1973 May; 40(3):327-34. PubMed ID: 4792335
    [No Abstract]   [Full Text] [Related]  

  • 17. [ -Mercaptopropionylglycine (Thiola) in the treatment of chronic hepatitis].
    Labò G; Barbara L; Gasbarrini G; Roda E; Schiavina M; Bonvicini F
    Minerva Med; 1972 Oct; 63(75):4055-9. PubMed ID: 4563998
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of subacute and chronic forms of hepatitis as well as of chronic degenerative liver diseases using Silymarin].
    Zirm KL
    Wien Med Wochenschr; 1973 May; 123(19):302-5. PubMed ID: 4702588
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial with arginine tidiacicate in symptomatic chronic persistent hepatitis.
    Rizzo S
    Int J Clin Pharmacol Res; 1986; 6(3):225-30. PubMed ID: 3527997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Limits of the method of comparative trials in hepatology. Apropos of the treatment of acute alcoholic hepatitis with corticoids].
    Hecht Y
    Med Chir Dig; 1974; 3(6):361-3. PubMed ID: 4617817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.